Q3 Earnings Estimate for ALHC Issued By KeyCorp

Key Points

• KeyCorp analysts predict that Alignment Healthcare will report a Q3 2025 EPS of ($0.07) and maintain an "Overweight" rating with a target price of $21.00.
• The company's recent quarterly earnings showed a positive surprise with reported EPS of $0.07, beating estimates, and a year-over-year revenue increase of 49.0%.
• Institutional ownership stands at 86.19%, indicating strong investor interest, with recent sales of shares by company insiders suggesting potential confidence in stock performance.

Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) - Investment analysts at KeyCorp issued their Q3 2025 earnings per share estimates for Alignment Healthcare in a note issued to investors on Sunday, August 24th. KeyCorp analyst M. Gillmor anticipates that the company will post earnings per share of ($0.07) for the quarter. KeyCorp currently has a "Overweight" rating and a $21.00 target price on the stock. The consensus estimate for Alignment Healthcare's current full-year earnings is ($0.69) per share. KeyCorp also issued estimates for Alignment Healthcare's Q4 2025 earnings at ($0.12) EPS, FY2025 earnings at ($0.16) EPS, FY2026 earnings at $0.05 EPS and FY2028 earnings at $0.65 EPS.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The company reported $0.07 EPS for the quarter, topping analysts' consensus estimates of ($0.07) by $0.14. The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $960.25 million. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.Alignment Healthcare's revenue was up 49.0% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.13) earnings per share. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS.

A number of other research analysts also recently weighed in on the company. Stephens upgraded Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Wall Street Zen downgraded Alignment Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, August 10th. Zacks Research upgraded Alignment Healthcare to a "hold" rating in a research note on Friday, August 8th. Finally, Barclays upgraded Alignment Healthcare from an "underweight" rating to an "equal weight" rating and boosted their price target for the company from $9.00 to $13.00 in a research note on Thursday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have issued a Hold rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $18.83.

Alignment Healthcare Stock Up 0.2%

Shares of NASDAQ:ALHC traded up $0.04 during mid-day trading on Wednesday, reaching $16.36. 1,760,791 shares of the stock were exchanged, compared to its average volume of 2,964,395. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 2.29. The company has a market cap of $3.24 billion, a P/E ratio of -58.43 and a beta of 1.16. Alignment Healthcare has a one year low of $8.65 and a one year high of $21.06. The stock's 50 day simple moving average is $13.93 and its 200-day simple moving average is $15.34.

Hedge Funds Weigh In On Alignment Healthcare

A number of institutional investors have recently modified their holdings of the business. State of Wyoming raised its holdings in shares of Alignment Healthcare by 133.9% during the 2nd quarter. State of Wyoming now owns 20,406 shares of the company's stock worth $286,000 after buying an additional 11,683 shares in the last quarter. Caxton Associates LLP acquired a new position in shares of Alignment Healthcare during the 2nd quarter worth $240,000. Tower Research Capital LLC TRC raised its holdings in shares of Alignment Healthcare by 2,098.8% during the 2nd quarter. Tower Research Capital LLC TRC now owns 19,679 shares of the company's stock worth $276,000 after buying an additional 18,784 shares in the last quarter. Tidal Investments LLC raised its holdings in shares of Alignment Healthcare by 4.9% during the 2nd quarter. Tidal Investments LLC now owns 18,094 shares of the company's stock worth $253,000 after buying an additional 852 shares in the last quarter. Finally, Gilder Gagnon Howe & Co. LLC acquired a new position in shares of Alignment Healthcare during the 2nd quarter worth $2,039,000. Institutional investors and hedge funds own 86.19% of the company's stock.

Insider Transactions at Alignment Healthcare

In other news, President Dawn Christine Maroney sold 30,000 shares of the business's stock in a transaction on Monday, July 14th. The stock was sold at an average price of $13.44, for a total transaction of $403,200.00. Following the completion of the transaction, the president owned 2,042,899 shares of the company's stock, valued at approximately $27,456,562.56. The trade was a 1.45% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Robert L. Scavo sold 60,000 shares of the business's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $14.60, for a total value of $876,000.00. Following the transaction, the insider directly owned 642,953 shares of the company's stock, valued at $9,387,113.80. This trade represents a 8.54% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 636,185 shares of company stock worth $9,235,468. Corporate insiders own 7.00% of the company's stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.